Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules

Area of Science:

• Cardiovascular Biology
• Hematology
• Molecular Medicine

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality.
• Platelets play a critical role in the pathogenesis of thrombosis and atherosclerosis, key contributors to CVD.
• Platelet activation is a complex process influenced by various factors including lipids, inflammatory mediators, peptide hormones, microRNAs (miRNAs), and oxidative stress.

Purpose of the Study:

• To review the molecules involved in platelet activation in the context of CVD.
• To identify molecules activated by platelets that contribute to CVD.
• To discuss the potential of targeting these molecules for therapeutic interventions against thrombosis and atherosclerosis.

Main Methods:

• Literature review focusing on molecular mechanisms of platelet activation in CVD.
• Analysis of studies investigating platelet-surface molecule interactions and their role in inflammation and thrombosis.
• Synthesis of information on potential therapeutic targets for CVD management.

Main Results:

• Platelet activation is modulated by diverse molecular entities, including lipids, signaling proteins, miRNAs, and oxidative stress.
• Surface molecules on activated platelets mediate interactions with other cells and chemokines, promoting inflammation and thrombosis.
• Specific molecules involved in platelet activation or activated by platelets show promise as predictive markers for CVD outcomes.

Conclusions:

• Identifying and targeting molecules that regulate platelet activation and interaction is a promising strategy for managing CVD.
• Dual therapy, combining receptor blockers with novel drugs, may enhance the clinical management of CVD patients.
• Further research into these molecular players can lead to novel therapeutic approaches to reduce thrombosis and atherosclerosis.